“…Meanwhile, both the number of DNA samples and detailed clinical data are increasing, and genetic and clinical data from over 10,000 patients has been collected from 102 collaborative centers. Based on this large-cohort data, we have published a series of studies demonstrating the mutational spectrum and clinical features caused by the representative deafness genes, including GJB2 (Tsukada et al 2010), CDH23 (Miyagawa et al 2012), KCNQ4 (Naito et al 2013), OTOF (Iwasa et al 2013(Iwasa et al , 2019, mitochondrial 1555A > G and 3243A > G (Yano et al 2014), SLC26A4 (Miyagawa et al 2014), LRTOMT (Ichinose et al 2015), GRXCR1 (Mori et al 2015a), PTPRQ (Sakuma et al 2015), COCH (Tsukada et al 2015a), TMPRSS3 (Miyagawa et al 2015d), STRC (Moteki et al 2016;Yokota et al 2019), LOXHD1 (Mori et al 2015b;Maekawa et al 2019), ACTG1 (Miyagawa et al 2015b;Miyajima et al 2020), MYO15A (Miyagawa et al 2015a), POU4F3 (Kitano et al 2017), WFS1 (Kobayashi et al 2018), CLDN14 (Kitano et al 2019), EYA4 (Shinagawa et al 2020a, b), TECTA (Yasukawa et al 2019), OTOA (Sugiyama et al 2019), and MYO6 (Miyagawa et al 2015c;Oka et al, 2020). These studies were performed between 2010 and 2020.…”